EMERYVILLE, Calif., Oct. 3, 2012 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, today announced its latest release of the company's Patient Access Intelligence solution, which streamlines the front-end registration and financial clearance process for healthcare providers. The...
ST. LOUIS, Oct. 3, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced today that Sigma Life Science, its innovative biological products and services research business, has launched Stemline® Pluripotent Culture Medium, a novel human pluripotent stem cell culture medium that provides...
SEATTLE, Oct. 3, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that the last patient has been enrolled in the Company's second Phase 3 clinical trial evaluating OMS302 for use during intraocular lens replacement (ILR) surgery. OMS302, one of...
SAN DIEGO, Oct. 3, 2012 /PRNewswire/ -- Scripps Health announced today that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute, which was established by Scripps Health in...
DENVER, Oct. 3, 2012 /PRNewswire/ -- MusclePharm Corporation (MSLP.OB), a nutritional supplement company focused on active lifestyles, announced today that it won three of the 23 top honors at the 2012 Bodybuilding.com Supplement Awards, awarded on September 29-30th at the 2012...
ROCKVILLE, Md., Oct. 3, 2012 /PRNewswire/ -- Community Radiology Associates (CRA), a division of RadNet, Inc., a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 237 fully-owned and operated outpatient imaging centers, announced it will...
NEWARK, Del., Oct. 3, 2012 /PRNewswire/ -- iBio, Inc. (NYSE MKT: IBIO) today announced issuance of a U.S. patent covering compositions of matter and methods of producing and formulating anthrax vaccines. The new patent is U.S. Patent 8,277,816 entitled "Bacillus Anthracis...
Common shares will begin trading on a consolidated and split-adjusted basis on October 5, 2012 QUÉBEC CITY, Oct. 3, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the issued and outstanding common shares of the...
REDWOOD CITY, Calif., Oct. 3, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced a decision by the European...
NES-ZIONA, Israel, Oct. 3, 2012 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE MKT: PBTH) today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for a new patent application covering the company's long-acting CTP-enhanced...
